Cargando…
Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality and continues to increase. Current standard of care for patients with HCC only provides limited therapeutic benefit. Development of innovative strategies is urgently needed. Experience with immunotherapy in HCC is...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750497/ https://www.ncbi.nlm.nih.gov/pubmed/26877890 http://dx.doi.org/10.4172/2155-9899.1000376 |